An actor who moved from South Africa to London to perform in the West End has revealed how cancer nearly wrecked his dream.

Theatre actor Jarryd Nurden has made a triumphant return to the stage just three months after undergoing life-saving surgery ...

In a remarkable display of resilience and passion for the performing arts, theatre actor Jarryd Nurden has made headlines by returning to the West End stage just six months after undergoing surgery ...

Jarryd Nurden's passion for theatre was ignited in his childhood in KwaZulu-Natal, South Africa. His early experiences in choirs fueled a desire to become a world-class performer. After years of ...

At the 2025 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium, Meara explored the ...

Theatre actor Jarryd Nurden has made a return to the West End stage just six months after undergoing surgery to remove half ...

Jarryd Nurden moved from South Africa to London to chase his West End dream, but was diagnosed with a rare lung cancer that ...

The German company developed 177Lu-edotreotide to treat SSTR-positive gastroenteropancreatic neuroendocrine tumors and expects an agency decision in August.

Prescription Drug User Fee Act (PDUFA) goal date set for August 28, 2026 Garching / Munich, Germany, November 13, 2025 – ITM ...

Jaclyn Hayes Lin was diagnosed with stage 4 pancreatic cancer when she was 32 weeks pregnant, but a drug from a clinical ...

The firm has begun dosing extensive-stage small cell and Merkel cell cancer patients with 225Ac-SSO110 in a Phase I/II trial.

Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to ...